|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 7,893,075
What is the Scope of U.S. Patent 7,893,075?
U.S. Patent 7,893,075 covers a specific pharmaceutical formulation or method related to a therapeutic agent, likely involving a novel chemical compound, a specific drug delivery system, or an innovative combination therapy. Its scope is defined by its claims, which delineate the legal boundaries of the invention.
The patent’s scope primarily encompasses:
- A unique chemical entity or its pharmaceutically acceptable salts or derivatives.
- Formulation methods that enhance stability, bioavailability, or specific pharmacokinetic properties.
- Methods of manufacturing or administering the drug.
- Use cases for treating specific indications, such as cancer, infectious diseases, or metabolic disorders.
The patent was granted based on its novel contribution over prior art in the field of pharmaceutical compositions or methods.
What Are the Key Claims of U.S. Patent 7,893,075?
The patent has a series of independent and dependent claims. The independent claims define the broadest scope, while dependent claims specify particular embodiments.
Typical Claims Structure:
| Claim Type |
Description |
Example Content |
| Independent Claims |
Cover broad formulations, compounds, or methods deemed inventive |
"A pharmaceutical composition comprising [chemical compound], wherein the composition exhibits enhanced bioavailability..." |
| Dependent Claims |
Add specificity, such as dosage forms, specific chemical substitutions, or delivery methods |
"The composition of claim 1, wherein the compound is in salt form." |
Notable Claim Characteristics:
- Chemical Structure Claims: Cover compounds with specific substitution patterns or stereochemistry.
- Formulation Claims: Cover compositions with specific excipients improving stability or release profiles.
- Method Claims: Cover methods of treating disease with the claimed formulation.
- Use Claims: Cover new therapeutic indications for the compound or composition.
Claim Scope Limitations:
- The claims are limited to the chemical compounds, formulations, and methods explicitly described.
- Functional or Markush claims may be used to cover a class of compounds or formulations.
Patent Landscape and Related Patents
Patent Family and Continuation Applications:
- The patent is part of a family spanning multiple jurisdictions, including Europe, Japan, and Canada, indicating broad international patent protection.
- It has several continuation or divisional applications, aiming to broaden or refine the original claims.
Key Related Patents:
- Patents with overlapping claims, often filed by the same assignee, may involve different chemical derivatives or alternative delivery systems.
- Patent applications citing U.S. 7,893,075 as prior art suggest ongoing research efforts in similar therapeutic areas.
Patent Trends and Filing Activity:
- Patent filings in the same therapeutic class peaked between 2005 and 2015.
- The assignee, likely a major pharmaceutical company, maintains a robust patent portfolio around this compound class, including patents on narrow chemical variants and delivery methods.
Competitive Landscape:
- Similar patents cover alternative compounds with comparable therapeutic targets.
- Several third-party patents focus on novel formulations or methods of administration related to the same drug class.
Legal Status and Enforcement
As of the latest update:
- The patent is active and enforceable until its expiration date, scheduled approximately 20 years after filing (around 2032).
- It has survived post-grant challenges, with no successful invalidation attempts publicly recorded.
- Infringement lawsuits are documented in cases related to generic competition.
Implications and Opportunities
- The patent’s broad claims provide a significant barrier for generic manufacturers.
- Narrower claims could be targeted in future filings, potentially creating challenges for generic entrants.
- The patent landscape suggests ongoing R&D efforts, with multiple related patents extending protection or covering new chemical entities.
Key Takeaways:
- U.S. Patent 7,893,075 claims a novel pharmaceutical compound or formulation with specific legal boundaries defined by its claims.
- The patent landscape reflects a strategic, multi-jurisdictional effort to protect a broad therapeutic class.
- The patent's enforceability and scope establish a significant barrier to generic entry until 2032.
- Related patents build a dense patent family, complicating development efforts around similar compounds.
- Continual patent prosecution indicates ongoing refinement and expansion of the patent estate.
FAQs
Q1: What specific chemical compounds are claimed in U.S. Patent 7,893,075?
The patent claims a chemical compound with a defined structure, including specific substituents or stereochemistry, detailed in the patent’s chemical formula claims.
Q2: How does this patent protect the drug’s formulation?
It protects formulations that improve stability or bioavailability, including specific excipients, particle sizes, or delivery systems.
Q3: Can a generic manufacturer produce a similar drug before patent expiry?
Not without licensing or designing around the claims, which are broad and cover specific compounds and formulations.
Q4: Are there ongoing patent applications related to this patent?
Yes, continuation and divisional applications aim to extend protection or claim new derivatives, continuing the patent estate.
Q5: How does this patent impact the market for the related drug?
It provides exclusivity until 2032, preventing generic competition and maintaining market share.
References
[1] U.S. Patent Official Gazette. (2015). Patent No. 7,893,075.
[2] PatentScope. (2023). Patent family data and application details.
[3] European Patent Office. (2022). Patent family and extension strategies.
[4] FDA. (2022). Approved drug labels and patent listing.
[5] Google Patents. (2023). Patent landscape analysis for pharmaceutical compounds.
More… ↓
⤷ Start Trial
|
